| Net Cash Provided by (Used in) Operating Activities |
$33,034,000 |
USD |
-230% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$41,024,000 |
USD |
364% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$3,452,000 |
USD |
1.7% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
70,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
24,345,942 |
shares |
0.86% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$5,275,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$53,926,000 |
USD |
606% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$4,544,000 |
USD |
-41% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$9,627,000 |
USD |
6.7% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$169,695,000 |
USD |
15% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$162,621,000 |
USD |
-11% |
Q3 2025 |
Q3 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$97,302,000 |
USD |
-7.9% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$196,843,000 |
USD |
-11% |
Q3 2025 |
Q3 2025 |
| Property, Plant and Equipment, Gross |
$134,456,000 |
USD |
-7.7% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability, Current |
$18,544,000 |
USD |
-13% |
Q3 2025 |
Q3 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.04 |
pure |
0% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
$4,500,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$34,222,000 |
USD |
-15% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$25,840,000 |
USD |
7.1% |
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
$14,795,000 |
USD |
6.7% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$32,000,000 |
USD |
|
Q2 2025 |
Q3 2025 |
| Share-based Payment Arrangement, Expense |
$21,863,000 |
USD |
-17% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |